Dukes' classification as a prognostic factor in patients with squamous cell carcinoma of the thoracic esophagus undergoing combined-modality treatment

Medical Science Monitor

Volumn 12, Issue 10, 2006, Pages

  Da̧browski, Andrzej ^a   Skoczylas, Tomasz ^a   Ciechański, Aleksander ^a   Wallner, Grzegorz ^a   Zinkiewicz, Krzysztof ^a   Ćwik, Grzegorz ^a   Górczyński, Rafał ^b   Borowski, Andrzej ^c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Department of Surgery   (Poland)

^c Lubartów General Hospital   (Poland)

Author keywords

Combined modality treatment; Dukes' classification; Squamous cell carcinoma of the esophagus; Staging; TNM classification

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY; CONTROLLED STUDY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DRUG THERAPY, COMBINATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 33749671276     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Skinner DB, Ferguson MK, Soriano A et al: Selection of operation for esophageal cancer based on staging. Ann Surg, 1986; 204: 391-401
2. Wu PC, Posner MC: The role of surgery in the management of oesophageal cancer. Lancet Oncol, 2003; 4: 481-88
3. Leonard GD, McCaffrey JA, Maher M: Optimal therapy for oesophageal cancer. Cancer Treat Rev, 2003; 29: 275-82
4. Thomas P, Acri P, Doddoli C et al: Surgery for oesophageal cancer: current controversies. Ann Chir, 2003; 128: 351-58
5. Kaneko K, Ito H, Konishi K et al: Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus. Br J Cancer, 2003; 88: 18-24
6. th ed. New York: Wiley-Liss; 2002
7. Dukes CE: The classification of cancer of the rectum. J Pathol Bacteriol, 1932; 35: 323-32
8. Adachi Y, Suematsu T, Yasuda K et al: Clinicopathologic study of gastric cancer based on Dukes' classification. World J Surg, 1999; 23: 499-502
9. Tachibana M, Kinugasa S, Kumar Dhar D et al: Dukes' classification as a useful staging system in resectable squamous cell carcinoma of the esophagus. Virchows Arch, 2001; 438: 350-56
10. Le Prise E, Etienne PI, Meunier B et al: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer, 1994; 73: 1779-84
11. Bosset JG, Gignoux M, Triboulet JP et al: Chemioradiotherapy followed by surgery compared with surgery alone in squamous cancer of the esophagus. N Engl J Med, 1997; 337: 161-67
12. Urba SG, Oringer MB, Turrisi A et al: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol, 2001; 19: 305-13
13. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet, 2002; 359: 1727-33
14. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y: Systematic lymph node dissection for esophageal cancer-effective or not? Dis Esoph, 1994; 7: 2-13
15. Kaplan EL, Mejer P: Nonparametric estimation for incomplete observations. J Am Stat Assoc, 1952; 53: 457-81
16. Urschel JD, Sellke FW: Complications of salvage esophagectomy. Med Sci Monit, 2003; 9(7): RA173-80
17. Strutyńska-Karpińska M, Knast W, Markocka-Ma̧czka K: Advanced oesophageal cancer - search for the best procedure. Med Sci Monit, 2003; 9(4): LE3
18. Maciejewski R, Da̧browski A, Sory A, Polkowski W: Significance of gastric arterial network for the operative reconstruction of the oesophagus. Med Sci Monit, 1997; 3(1): 16-19
19. Schroder W, Gutschow CA, Holscher AH: Limited resection for early esophageal cancer? Langenbecks Arch Surg, 2003; 388: 88-94
20. Japanese Society for Esophageal Disease: Guidelines for the clinical and pathological studies on carcinoma of the esophagus. Jpn J Surg, 1976; 6: 79-86
21. Korst RJ, Rusch VW, Venkatraman E et al: Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg, 1998; 115: 660-70
22. Rusch VW: Should the esophageal cancer staging system be revised? J Thorac Cardiovasc Surg, 2003; 125: 992-93
23. Rice TW, Blackstone EH, Rybicki LA et al: Refining esophageal cancer staging. J Thorac Cardiovasc Surg, 2003; 125: 1103-13
24. Rice TW, Blackstone EH, Adelstein DJ et al: Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg, 2003; 125: 1091-92
25. Killinger WA, Rice TW, Adelstein DJ et al: Stage II esophageal carcinoma: the significance of T and N. J Thorac Cardiovasc Surg, 1996; 111: 935-40
26. Nozoe T, Sugimachi K: Simple staging criteria for esophageal carcinoma. Am J Clin Oncol, 2003; 26: 307-11